Research source
AI and gene tests together better predict prostate cancer spread risk.
Based on Assessing the clinical and biological associations between multimodal artificial intelligence (MMAI) and 22-gene genomic classifier (GC) in localized prostate cancer (PCa).
Published by Journal of Clinical OncologyJun 23, 2026
Peer-reviewed paperMedium evidenceHuman study
What researchers observed
Study showed AI and gene classifiers together improved prediction of cancer spread risk in an Asian patient group.
What this could mean
This could help researchers validate combined tests that better measure cancer risk and guide future study designs for treatment in prostate cancer.
What researchers still need to learn
Researchers still need to learn whether combined testing improves patient outcomes beyond risk prediction.